Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Demin Zhou

Showing results (61-70 of 121) with videos related to

Pageof 13
Sort By:
Plos One|November 27, 2014
c-Met targeting enhances the effect of irradiation and chemical agents against malignant colon cells harboring a KRAS mutationYingbo Li, Jinxi Wang, Xing Gao, et al.
Acta Biomaterialia|March 15, 2015
Development of next generation of therapeutic IFN-α2b via genetic code expansionBo Zhang, Huan Xu, Jingxian Chen, et al.
Theranostics|September 14, 2017
A Nanosystem of Amphiphilic Oligopeptide-Drug Conjugate Actualizing Both αvβ3 Targeting and Reduction-Triggered Release for MaytansinoidYanqin Liang, Suxin Li, Xiaoyou Wang, et al.
Chembiochem : a European Journal of Chemical Biology|April 26, 2008
Generation of shRNA pool library: a revision of the biological technique from the viewpoint of chemistryDemin Zhou, Cuiying Wang, Jing Zhang, et al.
Frontiers in Bioscience (Landmark Edition)|November 1, 2021
Effective inhibition of coronavirus replication by <i>Polygonum cuspidatum</i>Huan Xu, Jing Li, Shidong Song, et al.
Journal of Natural Products|February 4, 2016
Bioactive Constituents of Glycyrrhiza uralensis (Licorice): Discovery of the Effective Components of a Traditional Herbal MedicineShuai Ji, Ziwei Li, Wei Song, et al.
Plos One|December 17, 2008
Pyrvinium targets the unfolded protein response to hypoglycemia and its anti-tumor activity is enhanced by combination therapyDe-Hua Yu, James Macdonald, Guohong Liu, et al.
Experimental Hematology|November 15, 2020
Corrigendum to "AC220 and AraC cause differential inhibitory dynamics in patient-derived M5-AML with FLT3-ITD and, thus, ultimately distinct therapeutic outcomes" [Experimental Hematology 2017;45:36-44]Xiaoyu An, Jinping Liu, Na Wang, et al.
European Journal of Medicinal Chemistry|August 18, 2023
Novel mono- and multivalent N-acetylneuraminic acid glycoclusters as potential broad-spectrum entry inhibitors for influenza and coronavirus infectionXingxing Zhu, Yanliang Yi, Zibo Fan, et al.
Experimental Hematology|September 28, 2016
AC220 and AraC cause differential inhibitory dynamics in patient-derived M5-AML with FLT3-ITD and, thus, ultimately distinct therapeutic outcomesXiaoyu An, Jinping Liu, Na Wang, et al.
Pageof 13

Showing results (61-70 of 121) with videos related to

Sort By:
Pageof 13
Plos One|November 27, 2014
c-Met targeting enhances the effect of irradiation and chemical agents against malignant colon cells harboring a KRAS mutationYingbo Li, Jinxi Wang, Xing Gao, et al.
Acta Biomaterialia|March 15, 2015
Development of next generation of therapeutic IFN-α2b via genetic code expansionBo Zhang, Huan Xu, Jingxian Chen, et al.
Theranostics|September 14, 2017
A Nanosystem of Amphiphilic Oligopeptide-Drug Conjugate Actualizing Both αvβ3 Targeting and Reduction-Triggered Release for MaytansinoidYanqin Liang, Suxin Li, Xiaoyou Wang, et al.
Chembiochem : a European Journal of Chemical Biology|April 26, 2008
Generation of shRNA pool library: a revision of the biological technique from the viewpoint of chemistryDemin Zhou, Cuiying Wang, Jing Zhang, et al.
Frontiers in Bioscience (Landmark Edition)|November 1, 2021
Effective inhibition of coronavirus replication by <i>Polygonum cuspidatum</i>Huan Xu, Jing Li, Shidong Song, et al.
Journal of Natural Products|February 4, 2016
Bioactive Constituents of Glycyrrhiza uralensis (Licorice): Discovery of the Effective Components of a Traditional Herbal MedicineShuai Ji, Ziwei Li, Wei Song, et al.
Plos One|December 17, 2008
Pyrvinium targets the unfolded protein response to hypoglycemia and its anti-tumor activity is enhanced by combination therapyDe-Hua Yu, James Macdonald, Guohong Liu, et al.
Experimental Hematology|November 15, 2020
Corrigendum to "AC220 and AraC cause differential inhibitory dynamics in patient-derived M5-AML with FLT3-ITD and, thus, ultimately distinct therapeutic outcomes" [Experimental Hematology 2017;45:36-44]Xiaoyu An, Jinping Liu, Na Wang, et al.
European Journal of Medicinal Chemistry|August 18, 2023
Novel mono- and multivalent N-acetylneuraminic acid glycoclusters as potential broad-spectrum entry inhibitors for influenza and coronavirus infectionXingxing Zhu, Yanliang Yi, Zibo Fan, et al.
Experimental Hematology|September 28, 2016
AC220 and AraC cause differential inhibitory dynamics in patient-derived M5-AML with FLT3-ITD and, thus, ultimately distinct therapeutic outcomesXiaoyu An, Jinping Liu, Na Wang, et al.
Pageof 13